None
Conditions
Interventions
Group C:Ciprofol Injection
Group R:Remimazolam Tosilate for Injection
Group P:Propofol Injectable Emulsion
Sponsors
Baoding NO.1 central hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients who intend to undergo elective flexible ureteroscopic lithotripsy lithotripsy; 2. Age 18-75 years old; 3.BMI 18-30 kg/m^2 ; 4. ASAI. or Class II; 5. Mouth opening>=2.5cm; 6. Normal range of motion of head and neck; 7. Mallampati Class I or II; 8. The patient has fully understood the nature of the study, voluntarily participated in this trial and signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Severe cardiovascular and cerebrovascular diseases; 2. History of allergy to the trial drug; 3. History of neurological diseases; 4. Anticipated airway difficulties; 5. Use of sedatives; 6. Neuromuscular junction disorders 7. Liver and kidney function are obviously abnormal 8. Pregnant and lactating women; 9. Patients who are pre-medication and who are unwilling to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of hypotension during induction of anesthesia; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of postoperative recovery;Serum levels of central nervous system specific protein and interleukin-6 at 24 hours after operation; | — |
Countries
China
Contacts
Public ContactChaojun Liu
First Department of Anesthesia, the First Central Hospital of Baoding City, Hebei Province
Outcome results
None listed